Our Story
GoPath Diagnostics is a CAP-accredited, CLIA-certified molecular and anatomic pathology laboratory that provides high-complexity testing for oncology practices, hospitals, and biopharmaceutical partners. Our physician-scientists provide advanced NGS, FISH, and IHC testing to support precision medicine, clinical trial enrollment, and routine patient care.
Compliance & Accreditation
CAP 8662247
CLIA 14D2037930
NYSDoh (8512)
Whether you are helping families navigate cancer journeys or building robust diagnostic programs, GoPath works beside you - delivering clear, actionable results so you can confidently guide every treatment decision.
With over five decades of combined experience, our expert pathologists and scientists provide cutting-edge testing and diagnostic resources from our state-of-the-art CAP-accredited, CLIA-certified molecular diagnostic laboratory. Whether we are partnering with oncology practices and hospitals to create strong testing programs and streamlined billing, empowering biopharma to develop precise, effective treatments, or supporting patients with understandable reports, our mission is simple: to make the complex clear for everyone
With over five decades of combined experience, our expert pathologists and scientists provide cutting-edge testing and diagnostic resources from our state-of-the-art CAP-accredited, CLIA-certified molecular diagnostic laboratory. Whether we are partnering with oncology practices and hospitals to create strong testing programs and streamlined billing, empowering biopharma to develop precise, effective treatments, or supporting patients with understandable reports, our mission is simple: to make the complex clear for everyone
-
Services & Technology- GPIS Provider Portal: A secure, web-based platform providing 24/7 real-time access to patient lab results and high-resolution digital pathology images.
- EMR Integration: Fully interoperable with all major EMR and LIS platforms, supporting seamless data synchronization and clinical workflows.
- Professional Collaboration: We offer global diagnostic services and "Tech-Only" (TC) arrangements, enabling client pathologists to participate in the diagnostic process and capture professional component revenue.
-
Innovation & Operational Efficiency- In-House Expertise: GoPath maintains an in-house diagnostic team, IT, billing department, and customer support to ensureaccountability and data integrity.
- Rapid TAT: Our integrated workflow and on-site molecular scientists enable industry-leading turnaround times for critical oncological and genetic data.
- R&D Focus: As physician-scientists, we specialize in the rapid development and validation of new molecular tests to meet emerging clinical needs.
- Strategic Collaboration: We actively seek partnerships with biopharma and academic institutions for clinical research and diagnostic co-development.
-
Education & Authority Signals- Clinical Education: We provide clinicians and patients with evidence-based resources through a live case blog, technical webinars, and expert-led lectures.
- Patient Empowerment: GoPath simplifies complex genetic data into actionable knowledge to assist patients in understanding their diagnosis and prognosis.
GoPath Diagnostics: 13 years of Clinical Innovation
2011
Foundation Vision
Foundation Vision
2011
Foundation Vision
Foundation Vision
Dr. Jim Lu Launches GoPathDx.com, pioneering educational content bridging pathology and molecular science to advance clinical diagnostics.
2012
Laboratory Established
Laboratory Established
2012
Laboratory Established
Laboratory Established
GoPath Laboratories LLC was founded; opens 8,000 sq. ft. headquarters in Buffalo Grove, IL, with state-of-the-art pathology infrastructure.
2016
Full-Spectrum Services
Full-Spectrum Services
2016
Full-Spectrum Services
Full-Spectrum Services
Launches a comprehensive anatomic pathology to molecular diagnostics platform, positioning GoPath as a complete diagnostic partner for oncology practices.
2021
Strategic Partnerships
& Germline Testing
Strategic Partnerships
& Germline Testing
2021
Strategic Partnerships
& Germline Testing
Strategic Partnerships
& Germline Testing
Forms partnership with NorthShore University HealthSystem; launches ProstateNow hereditary germline panel for precision oncology.
2022
FDA-Cleared Innovation & Expansion
FDA-Cleared Innovation & Expansion
2022
FDA-Cleared Innovation & Expansion
FDA-Cleared Innovation & Expansion
Introduces FDA-cleared OncoTarget 500 CGP test; relocates to 30,000 sq. ft. facility; creates DigitCells for end-to-end digital pathology digitization.
2023
Regulatory Expansion
Regulatory Expansion
2023
Regulatory Expansion
Regulatory Expansion
Secures New York State License (NYSDOH 8512) for ProstateNow, enabling nationwide germline testing compliance.
2024
AI & Biopharma Leadership
AI & Biopharma Leadership
2024
AI & Biopharma Leadership
AI & Biopharma Leadership
Partners with Nucleai for AI-powered digital pathology; strengthens Biopharma division as central lab; launches OncoCore 32-gene NGS panel.
2025
Metabolic Disease Expansion
Metabolic Disease Expansion
2025
Metabolic Disease Expansion
Metabolic Disease Expansion
Launches DiabetesNow comprehensive genetic panel for diabetes diagnosis, classification, and management.